Derek Hicks Net Worth & Insider Trades
Derek Hicks - EVP, Intellia Therapeutics, Inc
What is Derek Hicks's Net Worth?
The current estimated net worth of Intellia Therapeutics, Inc's EVP, Derek Hicks, is estimated to be about $919.23K . Derek Hicks owns about 17,306 units of Intellia Therapeutics, Inc common stock. In the last year at Intellia Therapeutics, Inc, Derek Hicks has sold an estimated value of $67.42K worth.
What is Derek Hicks's Past Insider Trading?
Derek Hicks's largest sale order was 1,812 units , worth over $67.42K on January 6, 2023. In total, Derek Hicks has made about 3 transactions over a year of their time at Intellia Therapeutics, Inc. Derek Hicks usually trades in January, with the busiest year in 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Derek Hicks
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Derek Hicks's' Mailing Address?
- Mailing address is C/o Intellia Therapeutics, Inc. 40 Erie Street Suite 130 Cambridge MA 02139 MA
Intellia Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Stock Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| John M. Leonard, M.D. | 2020 | $580,000 | $319,000 | $2,722,890 | - | $13,786 | $3,635,676 |
| John M. Leonard, M.D. | 2019 | $559,200 | $307,560 | - | - | $37,026 | $903,786 |
| John M. Leonard, M.D. | 2018 | $550,000 | $302,500 | $7,818,005 | $1,011,713 | $26,112 | $9,708,330 |
| Glenn G. Goddard | 2020 | $407,000 | $146,520 | $1,001,063 | - | $8,928 | $1,563,511 |
| Glenn G. Goddard | 2019 | $383,000 | $153,200 | - | - | $5,644 | $541,844 |
| Glenn G. Goddard | 2018 | $67,718 | $51,652 | $1,896,825 | - | $218 | $2,016,413 |
| David Lebwohl, M.D. | 2020 | $298,378 | $228,000 | $1,549,720 | - | $2,690 | $2,078,788 |
| Andrew D. Schiermeier, Ph.D. | 2020 | $455,400 | $173,052 | $1,081,148 | - | $8,928 | $1,718,528 |
| Andrew D. Schiermeier, Ph.D. | 2019 | $440,000 | $167,200 | $611,897 | - | $8,778 | $1,227,875 |
| Andrew D. Schiermeier, Ph.D. | 2018 | $408,934 | $182,600 | $2,028,554 | $295,550 | $9,668 | $2,925,306 |
| Laura Sepp-Lorenzino, Ph.D. | 2020 | $420,000 | $184,800 | $1,081,148 | - | $4,578 | $1,690,526 |
| Laura Sepp-Lorenzino, Ph.D. | 2019 | $239,487 | $204,086 | $1,318,695 | - | $221 | $1,762,489 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1652130/000156459021021413/ntla-def14a_20210623.htm
What are Intellia Therapeutics, Inc's Past Insider Trades?
Intellia Therapeutics, Inc's most recent insider trade came on August 2, 2023 by Muna Bhanji who sold 265 units worth $11.22K . In the last 7 years, insiders at Intellia Therapeutics, Inc have sold an estimated value of $307.39M and bought an estimated value of $44.06M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are John Leonard, President and CEO, Francois Jean Formela, Director, and Jose Rivera, EVP .
Intellia Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||